Antidiabetic Repurposing
Antidiabetic Repurposing is a natural product repurposing strategy that specifically involves the redirection of bioactive compounds originally identified for non-diabetic indications toward the prevention, management, or treatment of diabetes and its complications through validated pharmacological mechanisms.
12
Publications
765
Citations
64
Authors
30
Institutions
Publications per year
2017–2026
8
Parents
12
Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk
Bowen Tang, Yunzhang Wang, Xia Jiang et al. · Neurology · 2022 · 69 citations · Full text
Medicine, Endocrinology, Genetics +13
1–5 of 12
64
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 64
30

Centre National de la Recherche Scientifique
Paris, France
1 h-index
2 publications
426 citations

Medical College of Wisconsin
Milwaukee, United States
1 h-index
9 publications
1.9K citations
Chinese University of Hong Kong
Hong Kong, Hong Kong
1 h-index
11 publications
1.5K citations
National Institute on Aging
Baltimore, United States
1 h-index
7 publications
483 citations

Karolinska Institutet
Stockholm, Sweden
1 h-index
7 publications
483 citations
Institute on Aging
San Francisco, United States
1 h-index
7 publications
483 citations
Délégation Provence et Corse
Marseille, France
1 h-index
2 publications
426 citations
University of Lisbon
Lisbon, Portugal
1 h-index
6 publications
270 citations
1–8 of 30
1 publications · 213 citations
1
h-index
1 publications · 137 citations
1
h-index
1 publications · 105 citations
1
h-index
1 publications · 69 citations
1
h-index
1 publications · 49 citations
1
h-index
1–5